Australia markets closed

Biocartis Group NV (BCART.BR)

Brussels - Brussels Delayed price. Currency in EUR
Add to watchlist
3.1700+0.0300 (+0.96%)
At close: 05:36PM CET
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
48,282
43,128
37,444
27,811
Cost of revenue
34,111
26,284
21,328
15,349
Gross profit
14,171
16,844
16,116
12,462
Operating expenses
Research development
49,981
45,783
39,844
36,842
Selling general and administrative
7,087
6,541
9,813
7,436
Total operating expenses
67,275
63,226
71,461
59,263
Operating income or loss
-53,104
-46,382
-55,345
-46,801
Interest expense
9,776
10,184
7,099
1,358
Income before tax
-68,911
-63,162
-64,167
-48,262
Income tax expense
-259
-228
-99
-109
Income from continuing operations
-68,652
-62,934
-64,068
-48,153
Net income
-68,652
-62,934
-64,068
-48,153
Net income available to common shareholders
-68,652
-62,934
-64,068
-48,153
Basic EPS
-
-1.11
-1.14
-0.94
Diluted EPS
-
-1.11
-1.14
-0.94
Basic average shares
-
56,611
56,075
51,171
Diluted average shares
-
56,611
56,075
51,171
EBITDA
-
-43,230
-47,349
-42,631